GEODE CAPITAL MANAGEMENT, LLC - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 247 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$42,625,429
-34.9%
5,104,236
+3.7%
0.01%
-37.5%
Q2 2023$65,460,063
+19.5%
4,921,808
+4.0%
0.01%
+14.3%
Q1 2023$54,786,258
+160530.5%
4,731,109
+13.5%
0.01%
+40.0%
Q4 2022$34,107
-99.9%
4,169,610
+3.5%
0.01%
+25.0%
Q3 2022$23,387,000
+29.6%
4,028,938
-1.3%
0.00%
+33.3%
Q2 2022$18,048,000
-48.4%
4,083,297
+6.3%
0.00%
-25.0%
Q1 2022$34,967,000
-53.9%
3,842,564
+3.7%
0.00%
-55.6%
Q4 2021$75,783,000
-14.9%
3,703,993
+6.3%
0.01%
-25.0%
Q3 2021$89,060,000
-27.1%
3,485,741
-0.2%
0.01%
-29.4%
Q2 2021$122,116,000
+12.6%
3,492,046
+7.3%
0.02%0.0%
Q1 2021$108,418,000
+40.3%
3,254,837
+9.3%
0.02%
+30.8%
Q4 2020$77,264,000
+212.1%
2,978,609
+18.7%
0.01%
+160.0%
Q3 2020$24,757,000
+223.2%
2,508,364
+13.0%
0.01%
+150.0%
Q2 2020$7,661,000
+16.4%
2,220,599
+3.3%
0.00%0.0%
Q1 2020$6,580,000
-68.4%
2,150,361
-46.9%
0.00%0.0%
Q4 2019$20,808,000
+111.5%
4,048,816
+112.3%
0.00%0.0%
Q3 2019$9,839,000
-16.4%
1,907,066
-2.0%
0.00%
-33.3%
Q2 2019$11,767,000
-7.0%
1,945,166
+11.1%
0.00%0.0%
Q1 2019$12,655,000
-45.7%
1,750,511
-44.4%
0.00%
-25.0%
Q4 2018$23,286,000
+203.8%
3,146,962
+122.1%
0.00%
+100.0%
Q3 2018$7,666,000
+85.3%
1,417,077
+21.6%
0.00%
+100.0%
Q2 2018$4,137,000
+99.5%
1,165,577
+15.2%
0.00%0.0%
Q1 2018$2,074,000
-15.7%
1,011,936
+8.5%
0.00%0.0%
Q4 2017$2,461,000
-46.4%
932,575
+6.6%
0.00%
-50.0%
Q3 2017$4,594,000
+94.5%
875,201
+31.9%
0.00%
+100.0%
Q2 2017$2,362,000
-30.4%
663,555
+1.1%
0.00%0.0%
Q1 2017$3,392,000
+51.6%
656,203
+11.4%
0.00%0.0%
Q4 2016$2,238,000
-56.6%
589,134
+2.5%
0.00%
-66.7%
Q3 2016$5,151,000
+50.3%
574,957
+18.0%
0.00%
+50.0%
Q2 2016$3,427,000
-14.8%
487,267
+3.0%
0.00%0.0%
Q1 2016$4,021,000
-26.9%
473,100
+12.9%
0.00%
-33.3%
Q4 2015$5,503,000
+269.3%
419,157
+2.8%
0.00%
+200.0%
Q3 2015$1,490,000
-34.0%
407,560
+3.9%
0.00%0.0%
Q2 2015$2,259,000
+6.0%
392,221
+7.4%
0.00%0.0%
Q1 2015$2,132,000
-20.7%
365,097
+6.4%
0.00%
-50.0%
Q4 2014$2,689,000
+81.0%
343,025
+13.2%
0.00%
+100.0%
Q3 2014$1,486,000
-11.3%
302,905
+11.7%
0.00%0.0%
Q2 2014$1,675,000
+18.5%
271,153
+2.5%
0.00%0.0%
Q1 2014$1,414,000
+16.4%
264,437
+13.8%
0.00%0.0%
Q4 2013$1,215,000
+0.2%
232,379
+6.1%
0.00%0.0%
Q3 2013$1,212,000
+192.8%
219,121
+33.5%
0.00%
Q2 2013$414,000164,1180.00%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q1 2022
NameSharesValueWeighting ↓
Madrone Advisors, LLC 16,415,933$137,073,04129.47%
ORACLE INVESTMENT MANAGEMENT INC 1,638,395$13,680,5984.20%
Decheng Capital Management III (Cayman), LLC 1,463,872$12,223,3314.08%
VK Services, LLC 2,632,784$21,983,7462.93%
Iron Triangle Partners LP 1,800,000$15,030,0002.20%
BOURNE LENT ASSET MANAGEMENT INC 574,350$4,795,8222.11%
Deep Track Capital, LP 6,000,000$50,100,0001.93%
Jackson Square Partners, LLC 6,933,865$57,897,7731.93%
ARK Investment Management 29,822,440$249,017,3701.90%
Nikko Asset Management Americas, Inc. 13,447,666$112,153,5341.34%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders